Diagnosis and Risk Stratification of non-alcoholic Steatohepatitis (NASH) - a Recommendation from Austrian Hepatologists

被引：0
|
作者：
Munda, Petra [1 ]
Aigner, Elmar [2 ]
Ferlitsch, Arnulf [3 ]
Gschwantler, Michael [4 ]
Hofer, Harald [5 ]
Maieron, Andreas [6 ]
Peck-Radosavljevic, Markus [7 ]
Stadlbauer-Koellner, Vanessa [8 ]
Wagner, Martin [8 ]
机构：
[1] Med Univ Wien, AKH Wien, Vienna, Austria
[2] Paracelsus Med Privatuniv, Uniklinikum Salzburg, PMU, Salzburg, Austria
[3] KH Barmherzige Bruder Wien, Vienna, Austria
[4] KA Wilhelminenspital, Vienna, Austria
[5] Klinikum Wels Grieskirchen, Wels, Austria
[6] Univ Klinikum St Polten, St Polten, Austria
[7] Klinikum Klagenfurt Worthersee, Klagenfurt, Austria
[8] Med Univ Graz, Graz, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2020年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P09
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [31] Non-invasive Diagnosis of Non-alcoholic Steatohepatitis (NASH) using a Panel of Fatty Acids
    Gjuka, Donjeta
    Song, Xiaoling
    Yoo, Wonbeak
    Yoo, Suk Young
    Wang, Jing
    Fallon, Michael B.
    Ioannou, George N.
    Harrison, Stephen A.
    Beretta, Laura
    HEPATOLOGY, 2015, 62 : 1255A - 1256A
  • [32] Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) - A growing epidemic
    South, K
    GASTROENTEROLOGY NURSING, 2006, 29 (02) : 169 - 169
  • [33] A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
    Younossi, Zobair M.
    Page, Sandra
    Rafiq, Nila
    Birerdinc, Aybike
    Stepanova, Maria
    Hossain, Noreen
    Afendy, Arian
    Younoszai, Zahra
    Goodman, Zachary
    Baranova, Ancha
    OBESITY SURGERY, 2011, 21 (04) : 431 - 439
  • [34] A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
    Zobair M. Younossi
    Sandra Page
    Nila Rafiq
    Aybike Birerdinc
    Maria Stepanova
    Noreen Hossain
    Arian Afendy
    Zahra Younoszai
    Zachary Goodman
    Ancha Baranova
    Obesity Surgery, 2011, 21 : 431 - 439
  • [35] Non-invasive diagnostic biomarkers for non-alcoholic steatohepatitis (NASH)
    Baranova, Ancha
    Jarrar, Mohammed
    Nugent, Clare
    Afendy, Arian
    Quigley, Caitlin
    Stepanova, Maria
    Elariny, Hazem
    Goodman, Zachary
    Chandhoke, Vikas
    Younossi, Zobair M.
    HEPATOLOGY, 2007, 46 (04) : 733A - 733A
  • [36] Association of non-alcoholic steatohepatitis (NASH) and inflammatory mediators from adipose tissue
    Madan, Atul K.
    Tichansky, David S.
    Fain, John
    GASTROENTEROLOGY, 2008, 134 (04) : A912 - A912
  • [37] Peculiar monocyte bioenergetic profile in non-alcoholic steatohepatitis (NASH)
    Sangineto, Moris
    Ciarnelli, Martina
    Romano, Antonino
    Villani, Rosanna
    Serviddio, Gaetano
    JOURNAL OF HEPATOLOGY, 2023, 78 : S750 - S751
  • [38] Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
    Sharma, Mithun
    Premkumar, Madhumita
    Kulkarni, Anand, V
    Kumar, Pramod
    Reddy, D. Nageshwar
    Rao, Nagaraja Padaki
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (01) : 40 - 50
  • [39] EFFECT OF CHRONIC ALCOHOL CONSUMPTION ON NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Seitz, H.
    ALCOHOL AND ALCOHOLISM, 2013, 48 : 6 - 6
  • [40] The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
    Mehta, Rohini
    Jeiran, Kianoush
    Koenig, Aaron B.
    Otgonsuren, Munkzhul
    Goodman, Zachary
    Baranova, Ancha
    Younossi, Zobair
    BMC MEDICAL GENETICS, 2016, 17
12345